Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Charpentier

Showing results (291-300 of 320) with videos related to

Pageof 32
Sort By:
Cancer Gene Therapy|December 23, 1999
Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitroA Dürrbach, E Angevin, P Poncet, et al.
Transplantation Proceedings|September 24, 1998
Bcl-2 and Bax expression on rat ischemic kidneyP Eschwege, V Paradis, M Conti, et al.
Biochemical and Biophysical Research Communications|July 31, 1992
Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor gammaB A Bernard, J M Bernardon, C Delescluse, et al.
Transplantation Proceedings|November 15, 2002
Value of lipid peroxidation by-products detected during the renal procurement on renal graft functionP Eschwège, S Droupy, M Conti, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2010
Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III studyB K Krämer, B Charpentier, L Bäckman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylationB Mollereau, M Deckert, O Déas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 26, 2006
FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and AustralasiaM Salvadori, K Budde, B Charpentier, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 10, 2013
Long-term exposure to belatacept in recipients of extended criteria donor kidneysB Charpentier, J O Medina Pestana, M Del C Rial, et al.
Medicine|April 20, 2000
Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Coopératif de l'Ile-de-France (GCIF)A Lahlou, P Lang, B Charpentier, et al.
Transplantation Proceedings|January 3, 2001
Treatment with mycophenolate mofetil in long-term renal transplant recipients: single-center experience in 28 patientsR Djeffal, C Hiesse, F Kriaa, et al.
Pageof 32

Showing results (291-300 of 320) with videos related to

Sort By:
Pageof 32
Cancer Gene Therapy|December 23, 1999
Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitroA Dürrbach, E Angevin, P Poncet, et al.
Transplantation Proceedings|September 24, 1998
Bcl-2 and Bax expression on rat ischemic kidneyP Eschwege, V Paradis, M Conti, et al.
Biochemical and Biophysical Research Communications|July 31, 1992
Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor gammaB A Bernard, J M Bernardon, C Delescluse, et al.
Transplantation Proceedings|November 15, 2002
Value of lipid peroxidation by-products detected during the renal procurement on renal graft functionP Eschwège, S Droupy, M Conti, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2010
Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III studyB K Krämer, B Charpentier, L Bäckman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylationB Mollereau, M Deckert, O Déas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 26, 2006
FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and AustralasiaM Salvadori, K Budde, B Charpentier, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 10, 2013
Long-term exposure to belatacept in recipients of extended criteria donor kidneysB Charpentier, J O Medina Pestana, M Del C Rial, et al.
Medicine|April 20, 2000
Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Coopératif de l'Ile-de-France (GCIF)A Lahlou, P Lang, B Charpentier, et al.
Transplantation Proceedings|January 3, 2001
Treatment with mycophenolate mofetil in long-term renal transplant recipients: single-center experience in 28 patientsR Djeffal, C Hiesse, F Kriaa, et al.
Pageof 32